ILLIMINOSS MEDICAL has announced its U.S. launch and commercial availability of the IlluminOss Bone Stabilization System for use in treatment of traumatic and fragility fractures associated with the aging population. / COURTESY ILLUMINOSS MEIDICAL INC.
EAST PROVIDENCE – IlluminOss Medical Inc. announced the United States launch and commercial availability of the IlluminOss Bone Stabilization System for use in skeletally mature patients in the treatment of traumatic and fragility fractures of the humerus, radius and ulna. The company received de novo approval from the Food and Drug Administration for the procedures…
Want More Free?
To access 2 more articles, please log in or register for free.
Registered users get access to a limited number of free articles every month.
Want to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.
